High-Dose Argatroban for Heparin-Induced Thrombocytopenia in a Child Using a Ventricular Assist Device

    loading  Checking for direct PDF access through Ovid

Abstract

A 10-year-old boy who was receiving support from a ventricular assist device (VAD) experienced heparin-induced thrombocytopenia that was successfully treated with high-dose argatroban infusion to attain therapeutic activated partial thromboplastin time in spite of high serum argatroban levels. This case also highlights bolus argatroban dosing for VAD change in the setting of persistent ventricular fibrillation.

Related Topics

    loading  Loading Related Articles